The GPHF-Minilab® - Focusing on Prevalent Medicines against Infectious Diseases

The GPHF-Minilab focuses its work on a range of more than fifty drug compounds instantly life-threatened when diluted down to nothing. They have been selected on the basis of prevailing prescription practices, public health interest and existing counterfeit case reports, the current short list consisting of common antimicrobials, anthelminthics, anti(retro)virals, antimalarials, antituberculosis and some other medicines including their appropriate fixed-dose combination products. The list is regularly extended.

Antimicrobials
Amoxicillin Ampicillin Cefalexin  
Cefixime Cefuroxime Chloramphenicol 
Ciprofloxacin Cloxacillin  Erythromycin 
Levofloxacin Metronidazole Moxifloxacin 
Phenoxymethylpenicillin  Sulfamethoxazole Tetracycline 
Trimethoprim 
 
Antimalarials
Amodiaquine Artemether Artesunate  
Atovaquone Chloroquine Halofantrine 
Lumefantrine Mefloquine  Primaquine 
Proguanil Pyrimethamine Quinine  
Sulfadoxine 
 
Anti(retro)virals
Didanosine Indinavir Lamivudine  
Nevirapine Oseltamivir Stavudine  
Zidovudine 
 
Anti-TB medicines
Ciprofloxacin Ethambutol Isoniazid 
Levofloxacin Moxifloxacin Prothionamide 
Pyrazinamide  Rifampicin 
 
Anthelminthics
Albendazole Mebendazole Praziquantel 
 
Antifungals
Griseofulvin 
 
Non Anti-Infectives
Acetylsalicylic acid Aminophylline Furosemide  
Glibenclamide Paracetamol Prednisolone  
Salbutamol